Mitoxantrone Completed Phase 1 Trials for Childhood B Acute Lymphoblastic Leukemia / Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma / Childhood T Acute Lymphoblastic Leukemia / Recurrent Childhood Acute Lymphoblastic Leukemia / Recurrent Childhood Lymphoblastic Lymphoma Treatment

Indications	Status	Purpose	Phase
DBCOND0047846 (Childhood B Acute Lymphoblastic Leukemia) DBCOND0030859 (Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma) DBCOND0036552 (Childhood T Acute Lymphoblastic Leukemia) DBCOND0028597 (Recurrent Childhood Acute Lymphoblastic Leukemia) DBCOND0028598 (Recurrent Childhood Lymphoblastic Lymphoma)	Completed	Treatment	1

clinicaltrials.gov Identifier	Title	Drugs
NCT01403415	Temsirolimus, Dexamethasone, Mitoxantrone Hydrochloride, Vincristine Sulfate, and Pegaspargase in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma	Methotrexate (DB00563) Mitoxantrone (DB01204) Dexamethasone (DB01234) Sirolimus (DB00877) Temsirolimus (DB06287) Sulfate ion (DB14546) Vincristine (DB00541) Asparaginase Escherichia coli (DB00023) Pegaspargase (DB00059)